This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thompson Coburn Leads Lorillard To Defense Victory In West Virginia Tobacco Trial

ST. LOUIS, May 16, 2013 /PRNewswire/ -- A near-complete defense victory capped more than 15 years of work by a Thompson Coburn Consumer Products trial team for client Lorillard Tobacco. Five major tobacco companies were named in the case, filed by 700 West Virginia smokers who tried to establish they were harmed by using tobacco.

On May 15, a jury deliberated less than four hours before entering a defense verdict on all but one of the six claims filed against the tobacco companies.

The month-long trial was the fourth attempt at trying the case; all three earlier attempts resulted in mistrials.

"This is a great victory for Lorillard and the other defendants," said Mike Minton , a Thompson Coburn partner and lead attorney for Lorillard. "After repeated attempts to bring this case to trial, we are proud and gratified that the jury has carefully considered the issues and rejected the majority of the plaintiffs' claims."

Partner Liz Blackwell served as second chair for Lorillard in the case. Partners Sue Werstak , Heather Counts , and Dan Orlowsky rounded out the trial team.  

This most recent trial is particularly noteworthy, Minton said, because Lorillard and the defendants were unable to present evidence related to a key defense in nearly all tobacco litigation: The fact that individual plaintiffs made the personal choice to smoke.

Despite that significant obstacle, the West Virginia jury found against the smokers on claims of failure to warn, negligence, design defect, breach of warranty, fraudulent concealment, and entitlement to punitive damages. The jurors found for the plaintiffs on one question related to the sale of ventilated filter cigarettes.

Thompson Coburn also secured a significant victory in the course of the litigation during one of the previous mistrials. In that trial, Lorillard successfully excluded two of the plaintiffs' addiction experts. Thompson Coburn attorneys argued that if the defendants could not raise the issue of personal choice, then the plaintiffs should not be allowed to present evidence claiming that nicotine affected a person's ability to forgo smoking.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs